Bionpharma Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is IVABRADINE HYDROCHLORIDE, with a corresponding US DMF Number 33077.
Remarkably, this DMF maintains an Active status since its submission on September 21, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 05, 2018, and payment made on September 21, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II